EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrative Multi-Omics Reveal Metabolic Reprogramming by Ketogenic Diet in Melanoma Xenografts

Rohit Dnyansagar, Natalie Bordag iD, Rodolphe Poupardin iD, Julia Tevini iD, Victoria E Stefan iD, Sophia Derdak, Martin Bilban, Nikolaus Fortelny, Barbara Kofler iD, Roland Lang iD, Daniela D Weber iD

Biomolecules · 22.07.2026 · 16 (7) · 1071

DOI: 10.3390/biom16071071 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 22.07.2026. Verfasst von Rohit Dnyansagar und 10 weiteren Autor:innen. Beteiligte Einrichtung: Research Program for Receptor Biochemistry and Tumor Metabolism, Department of Pediatrics, University Hospital of the Paracelsus Medical Private Univ…. Hauptthemen laut MEDLINE: Melanoma, Diet, Ketogenic. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union, EU, Research & Innovation Fund of the Paracelsus Medical Private University Salzburg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The ketogenic diet (KD) has demonstrated anti-proliferative effects across multiple tumor types, yet the underlying metabolic and transcriptomic mechanisms remain incompletely understood. This study employed integrated multi-omics analysis combining targeted metabolomics and RNA sequencing to elucidate KD-induced metabolic reprogramming in BRAF/NRAS wild-type, BRAF mutant, and NRAS mutant melanoma xenografts, which showed delayed tumor growth when treated with the KD. Despite pronounced metabolic and transcriptional heterogeneity across models with minimal overlap in individual KD-responsive genes, pathway-level analysis revealed convergent biological signatures. Using VIP score-based integration and supervised latent variable modeling (mixOmics DIABLO), we identified consistent KD-associated alterations in cancer-related pathways including the PI3K-Akt, MAPK, sphingolipid as well as HIF-1 signaling pathways. The KD enhanced sphingomyelin and ceramide levels and additionally induced transcriptional signatures, indicating increased ceramide synthesis and reduced ceramide breakdown. Moreover, the KD reduced transcript levels of genes encoding critical tumor regulators, including PI3K, AKT, HIF, MEK, and ERK. These findings demonstrate that despite metabolic and transcriptomic heterogeneity, the KD drives coordinated metabolic reprogramming at the pathway level, indicative of shifting lipid metabolism toward pro-apoptotic ceramides and attenuating key oncogenic signaling cascades. Our results provide insights into the KD’s anti-tumor efficacy and identify metabolic nodes amenable to therapeutic intervention in melanoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaDiet, KetogenicAnimalsMetabolic ReprogrammingHumansMultiomicsMiceProto-Oncogene Proteins B-rafMetabolomicsCell Line, TumorSignal TransductionMembrane ProteinsXenograft Model Antitumor AssaysGene Expression Regulation, NeoplasticGTP Phosphohydrolases

Stichwörter der Autor:innen

cancer metabolismketogenic dietmelanomametabolomicsmulti-omics integrationtranscriptomics

Substanzen

Proto-Oncogene Proteins B-rafBRAF protein, humanMembrane ProteinsNRAS protein, humanGTP Phosphohydrolases

Autor:innen und Institutionen

  • Research Program for Receptor Biochemistry and Tumor Metabolism, Department of Pediatrics, University Hospital of the Paracelsus Medical Private University, 5020 Salzburg, Austria.
  • Department of Dermatology and Venereology, Medical University of Graz, 8010 Graz, Austria.
  • Cell Therapy Institute, Paracelsus Medical Private University, 5020 Salzburg, Austria.
  • Department of Biosciences and Medical Biology, University of Salzburg, 5020 Salzburg, Austria.
  • Core Facilities, Medical University of Vienna, 1090 Vienna, Austria.
  • Department of Laboratory Medicine, Medical University of Vienna, 1090 Vienna, Austria.

ORCID-Profile: Natalie Bordag, Rodolphe Poupardin, Julia Tevini, Victoria E Stefan, Barbara Kofler, Roland Lang, Daniela D Weber

Förderung

  • European Union
  • EU
  • Research & Innovation Fund of the Paracelsus Medical Private University Salzburg
  • Austrian Science Fund
  • Children Cancer Foundation Salzburg, and Roche and Pierre Fabre

Zitieren

APA

Dnyansagar, R., Bordag, N., Poupardin, R., Tevini, J., Stefan, V. E., Derdak, S., Bilban, M., Fortelny, N., Kofler, B., Lang, R., & Weber, D. D. (2026). Integrative Multi-Omics Reveal Metabolic Reprogramming by Ketogenic Diet in Melanoma Xenografts. Biomolecules, 16(7), 1071. https://doi.org/10.3390/biom16071071

Vancouver

Dnyansagar R, Bordag N, Poupardin R, Tevini J, Stefan VE, Derdak S, et al. Integrative Multi-Omics Reveal Metabolic Reprogramming by Ketogenic Diet in Melanoma Xenografts. Biomolecules. 2026;16(7):1071. doi:10.3390/biom16071071

BibTeX
@article{Dnyansagar2026,
  author = {Dnyansagar, Rohit and Bordag, Natalie and Poupardin, Rodolphe and Tevini, Julia and Stefan, Victoria E and Derdak, Sophia and Bilban, Martin and Fortelny, Nikolaus and Kofler, Barbara and Lang, Roland and Weber, Daniela D},
  title = {Integrative Multi-Omics Reveal Metabolic Reprogramming by Ketogenic Diet in Melanoma Xenografts},
  journal = {Biomolecules},
  year = {2026},
  volume = {16},
  number = {7},
  pages = {1071},
  doi = {10.3390/biom16071071}
}
Kostenlos starten →